Omnicell, Inc.

NasdaqGS:OMCL Rapport sur les actions

Capitalisation boursière : US$2.0b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Omnicell Croissance future

Future contrôle des critères 3/6

Omnicell devrait augmenter ses bénéfices et son chiffre d'affaires de 116.1% et de 4.6% par an respectivement. Le BPA devrait croître de de 116.8% par an. Le rendement des capitaux propres devrait être 6.9% dans 3 ans.

Informations clés

116.1%

Taux de croissance des bénéfices

116.8%

Taux de croissance du BPA

Medical Equipment croissance des bénéfices17.6%
Taux de croissance des recettes4.6%
Rendement futur des capitaux propres7.0%
Couverture par les analystes

Good

Dernière mise à jour23 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

Omnicell, Inc.'s (NASDAQ:OMCL) Price Is Right But Growth Is Lacking After Shares Rocket 49%

Aug 02
Omnicell, Inc.'s (NASDAQ:OMCL) Price Is Right But Growth Is Lacking After Shares Rocket 49%

Is There Now An Opportunity In Omnicell, Inc. (NASDAQ:OMCL)?

Jul 11
Is There Now An Opportunity In Omnicell, Inc. (NASDAQ:OMCL)?

Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Jun 16
Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Omnicell (NASDAQ:OMCL) Is Making Moderate Use Of Debt

May 25
Omnicell (NASDAQ:OMCL) Is Making Moderate Use Of Debt

An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued

Mar 28
An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued

Omnicell, Inc.'s (NASDAQ:OMCL) 25% Dip In Price Shows Sentiment Is Matching Revenues

Feb 29
Omnicell, Inc.'s (NASDAQ:OMCL) 25% Dip In Price Shows Sentiment Is Matching Revenues

Is It Too Late To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?

Feb 23
Is It Too Late To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?

Omnicell Is Building A Strong Moat

Feb 22

Does Omnicell (NASDAQ:OMCL) Have A Healthy Balance Sheet?

Jan 15
Does Omnicell (NASDAQ:OMCL) Have A Healthy Balance Sheet?

Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Dec 25
Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price

Is Omnicell, Inc. (NASDAQ:OMCL) Trading At A 48% Discount?

Dec 06
Is Omnicell, Inc. (NASDAQ:OMCL) Trading At A 48% Discount?

Omnicell, Inc. (NASDAQ:OMCL) Analysts Just Slashed Next Year's Revenue Estimates By 14%

Nov 10
Omnicell, Inc. (NASDAQ:OMCL) Analysts Just Slashed Next Year's Revenue Estimates By 14%

Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 27% Undervaluation?

Sep 06
Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 27% Undervaluation?

Would Omnicell (NASDAQ:OMCL) Be Better Off With Less Debt?

Aug 08
Would Omnicell (NASDAQ:OMCL) Be Better Off With Less Debt?

Why Omnicell, Inc. (NASDAQ:OMCL) Could Be Worth Watching

Jul 02
Why Omnicell, Inc. (NASDAQ:OMCL) Could Be Worth Watching

A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL)

Jun 08
A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL)

Investors Could Be Concerned With Omnicell's (NASDAQ:OMCL) Returns On Capital

Apr 29
Investors Could Be Concerned With Omnicell's (NASDAQ:OMCL) Returns On Capital

Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?

Apr 11
Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?

At US$55.77, Is Omnicell, Inc. (NASDAQ:OMCL) Worth Looking At Closely?

Mar 23
At US$55.77, Is Omnicell, Inc. (NASDAQ:OMCL) Worth Looking At Closely?

Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 42% Undervaluation?

Feb 28
Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 42% Undervaluation?

Returns On Capital Are Showing Encouraging Signs At Omnicell (NASDAQ:OMCL)

Jan 15
Returns On Capital Are Showing Encouraging Signs At Omnicell (NASDAQ:OMCL)

We Think Omnicell (NASDAQ:OMCL) Can Stay On Top Of Its Debt

Jan 01
We Think Omnicell (NASDAQ:OMCL) Can Stay On Top Of Its Debt

Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 46% Undervaluation?

Nov 17
Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 46% Undervaluation?

Analysts Just Slashed Their Omnicell, Inc. (NASDAQ:OMCL) EPS Numbers

Nov 03
Analysts Just Slashed Their Omnicell, Inc. (NASDAQ:OMCL) EPS Numbers

Omnicell launches Specialty Pharmacy Services

Oct 11

Omnicell (NASDAQ:OMCL) Seems To Use Debt Quite Sensibly

Sep 30
Omnicell (NASDAQ:OMCL) Seems To Use Debt Quite Sensibly

Omnicell says advance services to drive profitable growth in long-run: Investor Day

Sep 20

Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?

Sep 15
Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?

Omnicell (NASDAQ:OMCL) Might Have The Makings Of A Multi-Bagger

Aug 31
Omnicell (NASDAQ:OMCL) Might Have The Makings Of A Multi-Bagger

Omnicell reports Q2 earnings miss; reaffirms FY22 guidance and issues Q3 outlook

Aug 04

Are Investors Undervaluing Omnicell, Inc. (NASDAQ:OMCL) By 41%?

Aug 03
Are Investors Undervaluing Omnicell, Inc. (NASDAQ:OMCL) By 41%?

Omnicell Fails To Justify Inclusion In Long-Only, Equity-Focused Portfolio

Jul 21

We Ran A Stock Scan For Earnings Growth And Omnicell (NASDAQ:OMCL) Passed With Ease

Jun 27
We Ran A Stock Scan For Earnings Growth And Omnicell (NASDAQ:OMCL) Passed With Ease

Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?

Jun 13
Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?

Omnicell's (NASDAQ:OMCL) Returns On Capital Are Heading Higher

May 30
Omnicell's (NASDAQ:OMCL) Returns On Capital Are Heading Higher

These 4 Measures Indicate That Omnicell (NASDAQ:OMCL) Is Using Debt Safely

May 05
These 4 Measures Indicate That Omnicell (NASDAQ:OMCL) Is Using Debt Safely

Prévisions de croissance des bénéfices et des revenus

NasdaqGS:OMCL - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20261,20230611224
12/31/20251,14419351118
12/31/20241,0912291178
6/30/20241,080-21152204N/A
3/31/20241,103-21165218N/A
12/31/20231,147-20126181N/A
9/30/20231,186-34165225N/A
6/30/20231,235-23127189N/A
3/31/20231,268-1848107N/A
12/31/20221,29661778N/A
9/30/20221,30948-555N/A
6/30/20221,258611877N/A
3/31/20221,1997298158N/A
12/31/20211,13278173232N/A
9/30/20211,07080195249N/A
6/30/202198760194242N/A
3/31/202191435164218N/A
12/31/202089232131186N/A
9/30/20208913886144N/A
6/30/202090649101164N/A
3/31/20209246985144N/A
12/31/20198976183145N/A
9/30/20198605498158N/A
6/30/20198364859117N/A
3/31/20198073855112N/A
12/31/20187873850104N/A
9/30/201877254861N/A
6/30/201875448-1927N/A
3/31/201874744N/A16N/A
12/31/201771331N/A25N/A
9/30/2017688-1N/A45N/A
6/30/2017678-6N/A72N/A
3/31/2017670-9N/A56N/A
12/31/201669610N/A50N/A
9/30/20166518N/A54N/A
6/30/201659914N/A40N/A
3/31/201653924N/A44N/A
12/31/201548531N/A38N/A
9/30/201547632N/A37N/A
6/30/201546332N/A50N/A
3/31/201545531N/A75N/A
12/31/201444131N/A65N/A
9/30/201442528N/A49N/A
6/30/201440729N/A59N/A
3/31/201439527N/A52N/A
12/31/201338124N/A55N/A
9/30/201336523N/A53N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: OMCL devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance plus rapide que le taux d'épargne ( 2.5% ).

Bénéfices vs marché: OMCL devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance supérieure à la moyenne du marché.

Croissance élevée des bénéfices: OMCL devrait devenir rentable dans les 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de OMCL ( 4.6% par an) devrait croître plus lentement que le marché de US ( 8.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de OMCL ( 4.6% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de OMCL devrait être faible dans 3 ans ( 6.9 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y